{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:24:23Z","timestamp":1731043463348,"version":"3.28.0"},"reference-count":47,"publisher":"Texas Heart Institute Journal","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>The United States Food and Drug Administration restricts the use of implantable cardiac pressure monitors to patients with New York Heart Association (NYHA) class III heart failure (HF). We investigated whether single-pressure monitoring could predict survival in HF patients as part of a model constructed using data from the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) trial.<\/jats:p>\n        <jats:p>We validated survival models in 204 patients, using all-cause 180-day mortality. Two levels of model complexity were tested: 1) a simplified 1-pressure model based on pulmonary artery mean pressure ([PAM]1P) (information obtainable from an implanted intracardiac monitor alone), and 2) a pair of 5-variable risk score models based on right atrial pressure (RAP) + pulmonary capillary wedge pressure (PCWP) ([RAP+PCWP]5V) and on RAP + PAM ([RAP+PAM]5V). The more complex models used 5 dichotomous variables: a congestion index above a certain threshold value, baseline systolic blood pressure of &lt;100 mmHg, baseline blood urea nitrogen level of \u2265 34 mg\/dL, need for cardiopulmonary resuscitation or mechanical ventilation, and posttreatment NYHA class IV status. The congestion index was defined as posttreatment RAP+PCWP or posttreatment RAP+PAM, with congestion thresholds of 34 and 42 mmHg, respectively (median pulmonary catheter indwelling time, 1.9 d).<\/jats:p>\n        <jats:p>The 5-variable models predicted survival with areas under the curve of 0.868 for the (RAP+PCWP)5V model and 0.827 for the (RAP+PAM)5V model, whereas the 1-pressure model predicted survival with an area under the curve of 0.718. We conclude that decongestion as determined by hemodynamic assessment predicts survival in HF patients and that it may be the final pathway for treatment benefit despite improvements in pharmacologic intervention since the ESCAPE trial.<\/jats:p>","DOI":"10.14503\/thij-21-7587","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T21:19:02Z","timestamp":1661375942000},"source":"Crossref","is-referenced-by-count":0,"title":["Decongestion Models and Metrics in Acute Heart Failure: ESCAPE Data in the Age of the Implantable Cardiac Pressure Monitor"],"prefix":"10.14503","volume":"49","author":[{"given":"David","family":"Paniagua","sequence":"first","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"},{"name":"Department of Adult Cardiology, Texas Heart Institute, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn N.","family":"Levine","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine D.","family":"Cornwell","sequence":"additional","affiliation":[{"name":"Section of Thoracic Surgery, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Section of Thoracic Surgery, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswajit","family":"Kar","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"},{"name":"The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali E.","family":"Denktas","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony S.","family":"Ma","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5628","reference":[{"issue":"17","key":"i1526-6702-49-4-e217587-b1","series-title":"J Am Coll Cardiol","first-page":"e263","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","year":"2022","unstructured":"Heidenreich\n              PA,\n            \n            \n              Bozkurt\n              B,\n            \n            \n              Aguilar\n              D,\n            \n            \n              Allen\n              LA,\n            \n            \n              Byun\n              JJ,\n            \n            \n              Colvin\n              MM,\n            \n          \n          .\n\t\t\t\t\t2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.\n\t\t\t\t\tJ Am Coll Cardiol2022;79(17):e263\u2013e421."},{"issue":"8","key":"i1526-6702-49-4-e217587-b2","series-title":"Eur J Heart Fail","first-page":"891","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","year":"2016","unstructured":"Ponikowski\n              P,\n            \n            \n              Voors\n              AA,\n            \n            \n              Anker\n              SD,\n            \n            \n              Bueno\n              H,\n            \n            \n              Cleland\n              JGF,\n            \n            \n              Coats\n              AJS,\n            \n          \n          .\n\t\t\t\t\t2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.\n\t\t\t\t\tEur J Heart Fail2016;18(8):891\u2013975."},{"issue":"10017","key":"i1526-6702-49-4-e217587-b3","series-title":"Lancet","first-page":"453","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","year":"2016","unstructured":"Abraham\n              WT,\n            \n            \n              Stevenson\n              LW,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Lindenfeld\n              JA,\n            \n            \n              Bauman\n              JG,\n            \n            \n              Adamson\n              PB,\n            \n            CHAMPION Trial Study Group.\n\t\t\t\t\t\n          Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.\n\t\t\t\t\tLancet2016;387(10017):453\u201361."},{"issue":"9943","key":"i1526-6702-49-4-e217587-b4","series-title":"Lancet","first-page":"583","article-title":"Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial","volume":"384","year":"2014","unstructured":"Hindricks\n              G,\n            \n            \n              Taborsky\n              M,\n            \n            \n              Glikson\n              M,\n            \n            \n              Heinrich\n              U,\n            \n            \n              Schumacher\n              B,\n            \n            \n              Katz\n              A,\n            \n          \n          .\n\t\t\t\t\tImplant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.\n\t\t\t\t\tLancet2014;384(9943):583\u201390."},{"issue":"13","key":"i1526-6702-49-4-e217587-b5","series-title":"JAMA","first-page":"1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","year":"2005","unstructured":"Binanay\n              C,\n            \n            \n              Califf\n              RM,\n            \n            \n              Hasselblad\n              V,\n            \n            \n              O'Connor\n              CM,\n            \n            \n              Shah\n              MR,\n            \n            \n              Sopko\n              G,\n            \n          \n          .\n\t\t\t\t\tEvaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.\n\t\t\t\t\tJAMA2005;294(13):1625\u201333."},{"issue":"6","key":"i1526-6702-49-4-e217587-b6","series-title":"Am J Cardiol","first-page":"854","article-title":"Usefulness of the sum of pulmonary capillary wedge pressure and right atrial pressure as a congestion index that prognosticates heart failure survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)","volume":"118","year":"2016","unstructured":"Ma\n              TS,\n            \n            \n              Paniagua\n              D,\n            \n            \n              Denktas\n              AE,\n            \n            \n              Jneid\n              H,\n            \n            \n              Kar\n              B,\n            \n            \n              Chan\n              W,\n            \n            \n              Bozkurt\n              B.\n            \n          \n          Usefulness of the sum of pulmonary capillary wedge pressure and right atrial pressure as a congestion index that prognosticates heart failure survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).\n\t\t\t\t\tAm J Cardiol2016;118(6):854\u20139."},{"key":"i1526-6702-49-4-e217587-b7","unstructured":"Cardillo\n              G.\n            \n          \n          ROC curve. MathWorks [Internet].\n\t\t\t\t\tAvailable from: https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/19950-roc-curve [2008; cited 2022 Jan 20].","article-title":"ROC curve. MathWorks [Internet]"},{"key":"i1526-6702-49-4-e217587-b8","series-title":"BMC Bioinformatics","first-page":"77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","year":"2011","unstructured":"Robin\n              X,\n            \n            \n              Turck\n              N,\n            \n            \n              Hainard\n              A,\n            \n            \n              Tiberti\n              N,\n            \n            \n              Lisacek\n              F,\n            \n            \n              Sanchez\n              JC,\n            \n            \n              M\u00fcller\n              M.\n            \n          \n          pROC: an open-source package for R and S+ to analyze and compare ROC curves.\n\t\t\t\t\tBMC Bioinformatics2011;12:77."},{"issue":"10","key":"i1526-6702-49-4-e217587-b9","series-title":"J Clin Epidemiol","first-page":"1054","article-title":"Should scoring rules be based on odds ratios or regression coefficients?","volume":"55","year":"2002","unstructured":"Moons\n              KGM,\n            \n            \n              Harrell\n              FE,\n            \n            \n              Steyerberg\n              EW.\n            \n          \n          Should scoring rules be based on odds ratios or regression coefficients?\n          \n            J Clin Epidemiol\n          \n          2002;55(10):1054\u20135."},{"issue":"5","key":"i1526-6702-49-4-e217587-b10","series-title":"Korean J Anesthesiol","first-page":"441","article-title":"Survival analysis: part II - applied clinical data analysis","volume":"72","year":"2019","unstructured":"In\n              J,\n            \n            \n              Lee\n              DK.\n            \n          \n          Survival analysis: part II - applied clinical data analysis.\n\t\t\t\t\tKorean J Anesthesiol2019;72(5):441\u201357."},{"issue":"10","key":"i1526-6702-49-4-e217587-b11","series-title":"J Am Coll Cardiol","first-page":"1797","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","year":"2003","unstructured":"Nohria\n              A,\n            \n            \n              Tsang\n              SW,\n            \n            \n              Fang\n              JC,\n            \n            \n              Lewis\n              EF,\n            \n            \n              Jarcho\n              JA,\n            \n            \n              Mudge\n              GH,\n            \n            \n              Stevenson\n              LW.\n            \n          \n          Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.\n\t\t\t\t\tJ Am Coll Cardiol2003;41(10):1797\u2013804."},{"issue":"6","key":"i1526-6702-49-4-e217587-b12","series-title":"Am Heart J","first-page":"840","article-title":"Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure","volume":"140","year":"2000","unstructured":"Lucas\n              C,\n            \n            \n              Johnson\n              W,\n            \n            \n              Hamilton\n              MA,\n            \n            \n              Fonarow\n              GC,\n            \n            \n              Woo\n              MA,\n            \n            \n              Flavell\n              CM,\n            \n          \n          .\n\t\t\t\t\tFreedom from congestion predicts good survival despite previous class IV symptoms of heart failure.\n\t\t\t\t\tAm Heart J2000;140(6):840\u20137."},{"issue":"1","key":"i1526-6702-49-4-e217587-b13","series-title":"Circ Heart Fail","first-page":"54","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","year":"2012","unstructured":"Metra\n              M,\n            \n            \n              Davison\n              B,\n            \n            \n              Bettari\n              L,\n            \n            \n              Sun\n              H,\n            \n            \n              Edwards\n              C,\n            \n            \n              Lazzarini\n              V,\n            \n          \n          .\n\t\t\t\t\tIs worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.\n\t\t\t\t\tCirc Heart Fail2012;5(1):54\u201362."},{"issue":"6","key":"i1526-6702-49-4-e217587-b14","series-title":"Am Heart J","first-page":"908","article-title":"Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST","volume":"141","year":"2001","unstructured":"Shah\n              MR,\n            \n            \n              Stinnett\n              SS,\n            \n            \n              McNulty\n              SE,\n            \n            \n              Gheorghiade\n              M,\n            \n            \n              Zannad\n              F,\n            \n            \n              Uretsky\n              B,\n            \n          \n          .\n\t\t\t\t\tHemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST.\n\t\t\t\t\tAm Heart J2001;141(6):908\u201314."},{"issue":"19","key":"i1526-6702-49-4-e217587-b15","series-title":"Am J Cardiol","first-page":"1348","article-title":"Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy","volume":"66","year":"1990","unstructured":"Stevenson\n              LW,\n            \n            \n              Tillisch\n              JH,\n            \n            \n              Hamilton\n              M,\n            \n            \n              Luu\n              M,\n            \n            \n              Chelimsky-Fallick\n              C,\n            \n            \n              Moriguchi\n              J,\n            \n          \n          .\n\t\t\t\t\tImportance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.\n\t\t\t\t\tAm J Cardiol1990;66(19):1348\u201354."},{"issue":"11","key":"i1526-6702-49-4-e217587-b16","series-title":"Eur Heart J","first-page":"835","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","year":"2013","unstructured":"Ambrosy\n              AP,\n            \n            \n              Pang\n              PS,\n            \n            \n              Khan\n              S,\n            \n            \n              Konstam\n              MA,\n            \n            \n              Fonarow\n              GC,\n            \n            \n              Traver\n              B,\n            \n          \n          .\n\t\t\t\t\tClinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.\n\t\t\t\t\tEur Heart J2013;34(11):835\u201343."},{"issue":"9","key":"i1526-6702-49-4-e217587-b17","series-title":"N Engl J Med","first-page":"797","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","year":"2011","unstructured":"Felker\n              GM,\n            \n            \n              Lee\n              KL,\n            \n            \n              Bull\n              DA,\n            \n            \n              Redfield\n              MM,\n            \n            \n              Stevenson\n              LW,\n            \n            \n              Goldsmith\n              SR,\n            \n          \n          .\n\t\t\t\t\tDiuretic strategies in patients with acute decompensated heart failure.\n\t\t\t\t\tN Engl J Med2011;364(9):797\u2013805."},{"issue":"23","key":"i1526-6702-49-4-e217587-b18","series-title":"JAMA","first-page":"2533","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","year":"2013","unstructured":"Chen\n              HH,\n            \n            \n              Anstrom\n              KJ,\n            \n            \n              Givertz\n              MM,\n            \n            \n              Stevenson\n              LW,\n            \n            \n              Semigran\n              MJ,\n            \n            \n              Goldsmith\n              SR,\n            \n          \n          .\n\t\t\t\t\tLow-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.\n\t\t\t\t\tJAMA2013;310(23):2533\u201343."},{"issue":"24","key":"i1526-6702-49-4-e217587-b19","series-title":"N Engl J Med","first-page":"2296","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","year":"2012","unstructured":"Bart\n              BA,\n            \n            \n              Goldsmith\n              SR,\n            \n            \n              Lee\n              KL,\n            \n            \n              Givertz\n              MM,\n            \n            \n              O'Connor\n              CM,\n            \n            \n              Bull\n              DA,\n            \n          \n          .\n\t\t\t\t\tUltrafiltration in decompensated heart failure with cardiorenal syndrome.\n\t\t\t\t\tN Engl J Med2012;367(24):2296\u2013304."},{"issue":"8","key":"i1526-6702-49-4-e217587-b20","series-title":"Clin Chem","first-page":"1528","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data","volume":"52","year":"2006","unstructured":"Masson\n              S,\n            \n            \n              Latini\n              R,\n            \n            \n              Anand\n              IS,\n            \n            \n              Vago\n              T,\n            \n            \n              Angelici\n              L,\n            \n            \n              Barlera\n              S,\n            \n          \n          .\n\t\t\t\t\tDirect comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.\n\t\t\t\t\tClin Chem2006;52(8):1528\u201338."},{"issue":"25","key":"i1526-6702-49-4-e217587-b21","series-title":"J Am Coll Cardiol","first-page":"2090","article-title":"Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study","volume":"56","year":"2010","unstructured":"Eurlings\n              LWM,\n            \n            \n              van Pol\n              PEJ,\n            \n            \n              Kok\n              WE,\n            \n            \n              van Wijk\n              S,\n            \n            \n              Lodewijks-van der Bolt\n              C,\n            \n            \n              Balk\n              AHMM,\n            \n          \n          .\n\t\t\t\t\tManagement of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.\n\t\t\t\t\tJ Am Coll Cardiol2010;56(25):2090\u2013100."},{"issue":"16","key":"i1526-6702-49-4-e217587-b22","series-title":"J Am Coll Cardiol","first-page":"1733","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study","volume":"49","year":"2007","unstructured":"Jourdain\n              P,\n            \n            \n              Jondeau\n              G,\n            \n            \n              Funck\n              F,\n            \n            \n              Gueffet\n              P,\n            \n            \n              Le Helloco\n              A,\n            \n            \n              Donal\n              E,\n            \n          \n          .\n\t\t\t\t\tPlasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.\n\t\t\t\t\tJ Am Coll Cardiol2007;49(16):1733\u20139."},{"issue":"1","key":"i1526-6702-49-4-e217587-b23","series-title":"J Am Coll Cardiol","first-page":"53","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial","volume":"55","year":"2009","unstructured":"Lainchbury\n              JG,\n            \n            \n              Troughton\n              RW,\n            \n            \n              Strangman\n              KM,\n            \n            \n              Frampton\n              CM,\n            \n            \n              Pilbrow\n              A,\n            \n            \n              Yandle\n              TG,\n            \n          \n          .\n\t\t\t\t\tN-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.\n\t\t\t\t\tJ Am Coll Cardiol2009;55(1):53\u201360."},{"issue":"6","key":"i1526-6702-49-4-e217587-b24","series-title":"Eur J Heart Fail","first-page":"770","article-title":"Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score","volume":"21","year":"2019","unstructured":"O'Connor\n              C,\n            \n            \n              Fiuzat\n              M,\n            \n            \n              Mulder\n              H,\n            \n            \n              Coles\n              A,\n            \n            \n              Ahmad\n              T,\n            \n            \n              Ezekowitz\n              JA,\n            \n          \n          .\n\t\t\t\t\tClinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.\n\t\t\t\t\tEur J Heart Fail2019;21(6):770\u20138."},{"issue":"12","key":"i1526-6702-49-4-e217587-b25","series-title":"Eur J Heart Fail","first-page":"1300","article-title":"Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure)","volume":"12","year":"2010","unstructured":"Persson\n              H,\n            \n            \n              Erntell\n              H,\n            \n            \n              Eriksson\n              B,\n            \n            \n              Johansson\n              G,\n            \n            \n              Swedberg\n              K,\n            \n            \n              Dahlstr\u00f6m\n              U.\n            \n          \n          Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).\n\t\t\t\t\tEur J Heart Fail2010;12(12):1300\u20138."},{"issue":"4","key":"i1526-6702-49-4-e217587-b26","series-title":"JAMA","first-page":"383","article-title":"BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","year":"2009","unstructured":"Pfisterer\n              M,\n            \n            \n              Buser\n              P,\n            \n            \n              Rickli\n              H,\n            \n            \n              Gutmann\n              M,\n            \n            \n              Erne\n              P,\n            \n            \n              Rickenbacher\n              P,\n            \n          \n          .\n\t\t\t\t\tBNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.\n\t\t\t\t\tJAMA2009;301(4):383\u201392."},{"issue":"16","key":"i1526-6702-49-4-e217587-b27","series-title":"Circulation","first-page":"1671","article-title":"NT-proBNP (N-terminal pro-B-type natriuretic peptide)-guided therapy in acute decompensated heart failure: PRIMA II randomized controlled trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)","volume":"137","year":"2018","unstructured":"Stienen\n              S,\n            \n            \n              Salah\n              K,\n            \n            \n              Moons\n              AH,\n            \n            \n              Bakx\n              AL,\n            \n            \n              van Pol\n              P,\n            \n            \n              Kortz\n              RAM,\n            \n          \n          .\n\t\t\t\t\tNT-proBNP (N-terminal pro-B-type natriuretic peptide)-guided therapy in acute decompensated heart failure: PRIMA II randomized controlled trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).\n\t\t\t\t\tCirculation2018;137(16):1671\u201383."},{"issue":"6","key":"i1526-6702-49-4-e217587-b28","series-title":"N Engl J Med","first-page":"539","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure [published erratum appears in N Engl J Med 2019;380(11):1090]","volume":"380","year":"2019","unstructured":"Velazquez\n              EJ,\n            \n            \n              Morrow\n              DA,\n            \n            \n              DeVore\n              AD,\n            \n            \n              Duffy\n              CI,\n            \n            \n              Ambrosy\n              AP,\n            \n            \n              McCague\n              K,\n            \n          \n          .\n\t\t\t\t\tAngiotensin-neprilysin inhibition in acute decompensated heart failure [published erratum appears in N Engl J Med 2019;380(11):1090].\n\t\t\t\t\tN Engl J Med2019;380(6):539\u201348."},{"issue":"6","key":"i1526-6702-49-4-e217587-b29","series-title":"Tex Heart Inst J","first-page":"627","article-title":"Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure","volume":"38","year":"2011","unstructured":"Ma\n              TS,\n            \n            \n              Bozkurt\n              B,\n            \n            \n              Paniagua\n              D,\n            \n            \n              Kar\n              B,\n            \n            \n              Ramasubbu\n              K,\n            \n            \n              Rothe\n              CF.\n            \n          \n          Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure.\n\t\t\t\t\tTex Heart Inst J2011;38(6):627\u201338."},{"issue":"14","key":"i1526-6702-49-4-e217587-b30","series-title":"Circulation","first-page":"1433","article-title":"Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","year":"2008","unstructured":"Zile\n              MR,\n            \n            \n              Bennett\n              TD,\n            \n            \n              St John Sutton\n              M,\n            \n            \n              Cho\n              YK,\n            \n            \n              Adamson\n              PB,\n            \n            \n              Aaron\n              MF,\n            \n          \n          .\n\t\t\t\t\tTransition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.\n\t\t\t\t\tCirculation2008;118(14):1433\u201341."},{"issue":"11","key":"i1526-6702-49-4-e217587-b31","series-title":"J Am Coll Cardiol","first-page":"1073","article-title":"Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study","volume":"51","year":"2008","unstructured":"Bourge\n              RC,\n            \n            \n              Abraham\n              WT,\n            \n            \n              Adamson\n              PB,\n            \n            \n              Aaron\n              MF,\n            \n            \n              Aranda\n              JM\n              Jr,\n            \n            \n              Magalski\n              A,\n            \n          \n          .\n\t\t\t\t\tRandomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.\n\t\t\t\t\tJ Am Coll Cardiol2008;51(11):1073\u20139."},{"issue":"5","key":"i1526-6702-49-4-e217587-b32","series-title":"Congest Heart Fail","first-page":"248","article-title":"Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf ) trial","volume":"17","year":"2011","unstructured":"Adamson\n              PB,\n            \n            \n              Gold\n              MR,\n            \n            \n              Bennett\n              T,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Stevenson\n              LW,\n            \n            \n              Trupp\n              R,\n            \n          \n          .\n\t\t\t\t\tContinuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf ) trial.\n\t\t\t\t\tCongest Heart Fail2011;17(5):248\u201354."},{"issue":"1","key":"i1526-6702-49-4-e217587-b33","series-title":"Circ Heart Fail","first-page":"e003594","article-title":"Intracardiac pressures measured using an implantable hemodynamic monitor: relationship to mortality in patients with chronic heart failure","volume":"10","year":"2017","unstructured":"Zile\n              MR,\n            \n            \n              Bennett\n              TD,\n            \n            \n              El Hajj\n              S,\n            \n            \n              Kueffer\n              FJ,\n            \n            \n              Baicu\n              CF,\n            \n            \n              Abraham\n              WT,\n            \n          \n          .\n\t\t\t\t\tIntracardiac pressures measured using an implantable hemodynamic monitor: relationship to mortality in patients with chronic heart failure.\n\t\t\t\t\tCirc Heart Fail2017;10(1):e003594."},{"issue":"9766","key":"i1526-6702-49-4-e217587-b34","series-title":"Lancet","first-page":"658","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial [published erratum appears in Lancet 2012;379(9814):412]","volume":"377","year":"2011","unstructured":"Abraham\n              WT,\n            \n            \n              Adamson\n              PB,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Aaron\n              MF,\n            \n            \n              Costanzo\n              MR,\n            \n            \n              Stevenson\n              LW,\n            \n          \n          .\n\t\t\t\t\tWireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial [published erratum appears in Lancet 2012;379(9814):412].\n\t\t\t\t\tLancet2011;377(9766):658\u201366."},{"issue":"1","key":"i1526-6702-49-4-e217587-b35","series-title":"J Card Fail","first-page":"3","article-title":"CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system","volume":"17","year":"2011","unstructured":"Adamson\n              PB,\n            \n            \n              Abraham\n              WT,\n            \n            \n              Aaron\n              M,\n            \n            \n              Aranda\n              JM\n              Jr,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Smith\n              A,\n            \n          \n          .\n\t\t\t\t\tCHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.\n\t\t\t\t\tJ Card Fail2011;17(1):3\u201310."},{"issue":"15","key":"i1526-6702-49-4-e217587-b36","series-title":"J Am Coll Cardiol","first-page":"1875","article-title":"Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction","volume":"70","year":"2017","unstructured":"Givertz\n              MM,\n            \n            \n              Stevenson\n              LW,\n            \n            \n              Costanzo\n              MR,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Bauman\n              JG,\n            \n            \n              Ginn\n              G,\n            \n          \n          .\n\t\t\t\t\tPulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction.\n\t\t\t\t\tJ Am Coll Cardiol2017;70(15):1875\u201386."},{"issue":"10","key":"i1526-6702-49-4-e217587-b37","series-title":"Eur J Heart Fail","first-page":"1891","article-title":"Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF)","volume":"22","year":"2020","unstructured":"Angermann\n              CE,\n            \n            \n              Assmus\n              B,\n            \n            \n              Anker\n              SD,\n            \n            \n              Asselbergs\n              FW,\n            \n            \n              Brachmann\n              J,\n            \n            \n              Brett\n              ME,\n            \n          \n          .\n\t\t\t\t\tPulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).\n\t\t\t\t\tEur J Heart Fail2020;22(10):1891\u2013901."},{"issue":"8","key":"i1526-6702-49-4-e217587-b38","series-title":"Circ Heart Fail","first-page":"e006863","article-title":"Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study","volume":"13","year":"2020","unstructured":"Shavelle\n              DM,\n            \n            \n              Desai\n              AS,\n            \n            \n              Abraham\n              WT,\n            \n            \n              Bourge\n              RC,\n            \n            \n              Raval\n              N,\n            \n            \n              Rathman\n              LD,\n            \n          \n          .\n\t\t\t\t\tLower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study.\n\t\t\t\t\tCirc Heart Fail2020;13(8):e006863."},{"issue":"16","key":"i1526-6702-49-4-e217587-b39","series-title":"Circulation","first-page":"1719","article-title":"Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure","volume":"124","year":"2011","unstructured":"van Veldhuisen\n              DJ,\n            \n            \n              Braunschweig\n              F,\n            \n            \n              Conraads\n              V,\n            \n            \n              Ford\n              I,\n            \n            \n              Cowie\n              MR,\n            \n            \n              Jondeau\n              G,\n            \n          \n          .\n\t\t\t\t\tIntrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.\n\t\t\t\t\tCirculation2011;124(16):1719\u201326."},{"issue":"12","key":"i1526-6702-49-4-e217587-b40","series-title":"J Clin Epidemiol","first-page":"1503","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","year":"1995","unstructured":"Peduzzi\n              P,\n            \n            \n              Concato\n              J,\n            \n            \n              Feinstein\n              AR,\n            \n            \n              Holford\n              TR.\n            \n          \n          Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates.\n\t\t\t\t\tJ Clin Epidemiol1995;48(12):1503\u201310."},{"issue":"11","key":"i1526-6702-49-4-e217587-b41","series-title":"N Engl J Med","first-page":"993","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","year":"2014","unstructured":"McMurray\n              JJ,\n            \n            \n              Packer\n              M,\n            \n            \n              Desai\n              AS,\n            \n            \n              Gong\n              J,\n            \n            \n              Lefkowitz\n              MP,\n            \n            \n              Rizkala\n              AR,\n            \n          \n          .\n\t\t\t\t\tAngiotensin-neprilysin inhibition versus enalapril in heart failure.\n\t\t\t\t\tN Engl J Med2014;371(11):993\u20131004."},{"issue":"21","key":"i1526-6702-49-4-e217587-b42","series-title":"N Engl J Med","first-page":"1995","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","year":"2019","unstructured":"McMurray\n              JJV,\n            \n            \n              Solomon\n              SD,\n            \n            \n              Inzucchi\n              SE,\n            \n            \n              Kober\n              L,\n            \n            \n              Kosiborod\n              MN,\n            \n            \n              Martinez\n              FA,\n            \n          \n          .\n\t\t\t\t\tDapagliflozin in patients with heart failure and reduced ejection fraction.\n\t\t\t\t\tN Engl J Med2019;381(21):1995\u20132008."},{"issue":"3","key":"i1526-6702-49-4-e217587-b43","series-title":"Korean J Anesthesiol","first-page":"182","article-title":"Survival analysis: part I - analysis of time-to-event","volume":"71","year":"2018","unstructured":"In\n              J,\n            \n            \n              Lee\n              DK.\n            \n          \n          Survival analysis: part I - analysis of time-to-event.\n\t\t\t\t\tKorean J Anesthesiol2018;71(3):182\u201391."},{"issue":"5","key":"i1526-6702-49-4-e217587-b44","series-title":"JACC Heart Fail","first-page":"437","article-title":"Heart failure risk prediction models: what have we learned?","volume":"2","year":"2014","unstructured":"Levy\n              WC,\n            \n            \n              Anand\n              IS.\n            \n          \n          Heart failure risk prediction models: what have we learned?\n          \n            JACC Heart Fail\n          \n          2014;2(5):437\u20139."},{"issue":"5","key":"i1526-6702-49-4-e217587-b45","series-title":"Circ Heart Fail","first-page":"580","article-title":"Chronic ambulatory intracardiac pressures and future heart failure events","volume":"3","year":"2010","unstructured":"Stevenson\n              LW,\n            \n            \n              Zile\n              M,\n            \n            \n              Bennett\n              TD,\n            \n            \n              Kueffer\n              FJ,\n            \n            \n              Jessup\n              ML,\n            \n            \n              Adamson\n              P,\n            \n          \n          .\n\t\t\t\t\tChronic ambulatory intracardiac pressures and future heart failure events.\n\t\t\t\t\tCirc Heart Fail2010;3(5):580\u20137."},{"key":"i1526-6702-49-4-e217587-b46","series-title":"Am Heart J","first-page":"18","article-title":"Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF)","volume":"214","year":"2019","unstructured":"Lindenfeld\n              J,\n            \n            \n              Abraham\n              WT,\n            \n            \n              Maisel\n              A,\n            \n            \n              Zile\n              M,\n            \n            \n              Smart\n              F,\n            \n            \n              Costanzo\n              MR,\n            \n          \n          .\n\t\t\t\t\tHemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).\n\t\t\t\t\tAm Heart J2019;214:18\u201327."},{"issue":"10304","key":"i1526-6702-49-4-e217587-b47","series-title":"Lancet","first-page":"991","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","year":"2021","unstructured":"Lindenfeld\n              J,\n            \n            \n              Zile\n              MR,\n            \n            \n              Desai\n              AS,\n            \n            \n              Bhatt\n              K,\n            \n            \n              Ducharme\n              A,\n            \n            \n              Horstmanshof\n              D,\n            \n          \n          .\n\t\t\t\t\tHaemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.\n\t\t\t\t\tLancet2021;398(10304):991\u20131001."}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/49\/4\/article-e217587.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/thij\/article-pdf\/doi\/10.14503\/THIJ-21-7587\/3113353\/i1526-6702-49-4-e217587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/49\/4\/article-e217587.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/49\/4\/article-e217587.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:37:29Z","timestamp":1730993849000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/49\/4\/article-e217587.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":47,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.14503\/thij-21-7587","relation":{},"ISSN":["1526-6702","0730-2347"],"issn-type":[{"type":"electronic","value":"1526-6702"},{"type":"print","value":"0730-2347"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}